APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prescription Dermatological Medications

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Prescription Dermatological Medications Industry Growth and Trends Forecast to 2032

22 December 202590 pages

Choose your research edition.

Industry ResearchPrescription Dermatological Medications Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Prescription Dermatological Medications Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Prescription Dermatological Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prescription Dermatological Medications Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Prescription Dermatological Medications Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Prescription Dermatological Medications market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Prescription Dermatological Medications is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Prescription Dermatological Medications is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prescription Dermatological Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prescription Dermatological Medications include Novartis, Mylan Pharmaceuticals, Pfizer, Bristol-Myers Squibb, PharmaDerm, Galderma, Bausch Health, Barrier Therapeutics and Almirall, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Prescription Dermatological Medications market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Prescription Dermatological Medications market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Prescription Dermatological Medications market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Prescription Dermatological Medications.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Prescription Dermatological Medications market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Prescription Dermatological Medications Market by Company

Novartis

Mylan Pharmaceuticals

Pfizer

Bristol-Myers Squibb

PharmaDerm

Galderma

Bausch Health

Barrier Therapeutics

Almirall

Prescription Dermatological Medications Segment by Type

Oral

Topical

Prescription Dermatological Medications Segment by Application

Online Pharmacies

Hospital Pharmacies

Retail Pharmacies

Prescription Dermatological Medications Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prescription Dermatological Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prescription Dermatological Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prescription Dermatological Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prescription Dermatological Medications manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Prescription Dermatological Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Table 2. Major Company of Topical Table 3. Global Prescription Dermatological Medications Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Prescription Dermatological Medications Sales by Type (2021-2026) & (k units) Table 5. Global Prescription Dermatological Medications Sales Market Share in Volume by Type (2021-2026) Table 6. Global Prescription Dermatological Medications Sales by Type (2021-2026) & (US$ Million) Table 7. Global Prescription Dermatological Medications Sales Market Share in Value by Type (2021-2026) Table 8. Global Prescription Dermatological Medications Price by Type (2021-2026) & (US$/unit) Table 9. Global Prescription Dermatological Medications Sales by Type (2027-2032) & (k units) Table 10. Global Prescription Dermatological Medications Sales Market Share in Volume by Type (2027-2032) Table 11. Global Prescription Dermatological Medications Sales by Type (2027-2032) & (US$ Million) Table 12. Global Prescription Dermatological Medications Sales Market Share in Value by Type (2027-2032) Table 13. Global Prescription Dermatological Medications Price by Type (2027-2032) & (US$/unit) Table 14. North America Prescription Dermatological Medications Sales by Type (2021-2026) & (k units) Table 15. North America Prescription Dermatological Medications Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Prescription Dermatological Medications Sales by Type (2021-2026) & (k units) Table 17. Europe Prescription Dermatological Medications Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Prescription Dermatological Medications Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Prescription Dermatological Medications Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Prescription Dermatological Medications Sales by Type (2021-2026) & (k units) Table 21. Latin America Prescription Dermatological Medications Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Prescription Dermatological Medications Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Prescription Dermatological Medications Sales by Type (2021-2026) & (US$ Million) Table 24. Prescription Dermatological Medications Industry Trends Table 25. Prescription Dermatological Medications Industry Drivers Table 26. Prescription Dermatological Medications Industry Opportunities and Challenges Table 27. Prescription Dermatological Medications Industry Restraints Table 28. Global Prescription Dermatological Medications Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Prescription Dermatological Medications Revenue Market Share by Company (2021-2026) Table 30. Global Prescription Dermatological Medications Sales by Company (2021-2026) & (k units) Table 31. Global Prescription Dermatological Medications Sales Share by Company (2021-2026) Table 32. Global Prescription Dermatological Medications Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Prescription Dermatological Medications Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Prescription Dermatological Medications Major Company Production Sites and Headquarters Table 35. Global Prescription Dermatological Medications Company, Product Type & Application Table 36. Global Prescription Dermatological Medications Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Prescription Dermatological Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Prescription Dermatological Medications Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Prescription Dermatological Medications Sales by Region (2021-2026) & (k units) Table 41. Global Prescription Dermatological Medications Sales Market Share in Volume by Region (2021-2026) Table 42. Global Prescription Dermatological Medications Sales by Region (2021-2026) & (US$ Million) Table 43. Global Prescription Dermatological Medications Sales Market Share in Value by Region (2021-2026) Table 44. Global Prescription Dermatological Medications Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Prescription Dermatological Medications Sales by Region (2027-2032) & (k units) Table 46. Global Prescription Dermatological Medications Sales Market Share in Volume by Region (2027-2032) Table 47. Global Prescription Dermatological Medications Sales by Region (2027-2032) & (US$ Million) Table 48. Global Prescription Dermatological Medications Sales Market Share in Value by Region (2027-2032) Table 49. Global Prescription Dermatological Medications Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Prescription Dermatological Medications Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Prescription Dermatological Medications Sales by Application (2021-2026) & (k units) Table 52. Global Prescription Dermatological Medications Sales Market Share in Volume by Application (2021-2026) Table 53. Global Prescription Dermatological Medications Sales by Application (2021-2026) & (US$ Million) Table 54. Global Prescription Dermatological Medications Sales Market Share in Value by Application (2021-2026) Table 55. Global Prescription Dermatological Medications Price by Application (2021-2026) & (US$/unit) Table 56. Global Prescription Dermatological Medications Sales by Application (2027-2032) & (k units) Table 57. Global Prescription Dermatological Medications Sales Market Share in Volume by Application (2027-2032) Table 58. Global Prescription Dermatological Medications Sales by Application (2027-2032) & (US$ Million) Table 59. Global Prescription Dermatological Medications Sales Market Share in Value by Application (2027-2032) Table 60. Global Prescription Dermatological Medications Price by Application (2027-2032) & (US$/unit) Table 61. North America Prescription Dermatological Medications Sales by Application (2021-2026) & (k units) Table 62. North America Prescription Dermatological Medications Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Prescription Dermatological Medications Sales by Application (2021-2026) & (k units) Table 64. Europe Prescription Dermatological Medications Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Prescription Dermatological Medications Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Prescription Dermatological Medications Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Prescription Dermatological Medications Sales by Application (2021-2026) & (k units) Table 68. Latin America Prescription Dermatological Medications Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Prescription Dermatological Medications Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Prescription Dermatological Medications Sales by Application (2021-2026) & (US$ Million) Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Prescription Dermatological Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Novartis Prescription Dermatological Medications Product Portfolio Table 75. Novartis Recent Development Table 76. Mylan Pharmaceuticals Company Information Table 77. Mylan Pharmaceuticals Business Overview Table 78. Mylan Pharmaceuticals Prescription Dermatological Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Mylan Pharmaceuticals Prescription Dermatological Medications Product Portfolio Table 80. Mylan Pharmaceuticals Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer Prescription Dermatological Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Pfizer Prescription Dermatological Medications Product Portfolio Table 85. Pfizer Recent Development Table 86. Bristol-Myers Squibb Company Information Table 87. Bristol-Myers Squibb Business Overview Table 88. Bristol-Myers Squibb Prescription Dermatological Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Bristol-Myers Squibb Prescription Dermatological Medications Product Portfolio Table 90. Bristol-Myers Squibb Recent Development Table 91. PharmaDerm Company Information Table 92. PharmaDerm Business Overview Table 93. PharmaDerm Prescription Dermatological Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. PharmaDerm Prescription Dermatological Medications Product Portfolio Table 95. PharmaDerm Recent Development Table 96. Galderma Company Information Table 97. Galderma Business Overview Table 98. Galderma Prescription Dermatological Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Galderma Prescription Dermatological Medications Product Portfolio Table 100. Galderma Recent Development Table 101. Bausch Health Company Information Table 102. Bausch Health Business Overview Table 103. Bausch Health Prescription Dermatological Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Bausch Health Prescription Dermatological Medications Product Portfolio Table 105. Bausch Health Recent Development Table 106. Barrier Therapeutics Company Information Table 107. Barrier Therapeutics Business Overview Table 108. Barrier Therapeutics Prescription Dermatological Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Barrier Therapeutics Prescription Dermatological Medications Product Portfolio Table 110. Barrier Therapeutics Recent Development Table 111. Almirall Company Information Table 112. Almirall Business Overview Table 113. Almirall Prescription Dermatological Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Almirall Prescription Dermatological Medications Product Portfolio Table 115. Almirall Recent Development Table 116. North America Prescription Dermatological Medications Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. North America Prescription Dermatological Medications Sales by Country (2021-2026) & (k units) Table 118. North America Prescription Dermatological Medications Sales Market Share by Country (2021-2026) Table 119. North America Prescription Dermatological Medications Sales Forecast by Country (2027-2032) & (k units) Table 120. North America Prescription Dermatological Medications Sales Market Share Forecast by Country (2027-2032) Table 121. North America Prescription Dermatological Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Prescription Dermatological Medications Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Prescription Dermatological Medications Market Share by Country (2021-2026) Table 124. North America Prescription Dermatological Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Prescription Dermatological Medications Market Share Forecast by Country (2027-2032) Table 126. Europe Prescription Dermatological Medications Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Europe Prescription Dermatological Medications Sales by Country (2021-2026) & (k units) Table 128. Europe Prescription Dermatological Medications Sales Market Share by Country (2021-2026) Table 129. Europe Prescription Dermatological Medications Sales Forecast by Country (2027-2032) & (k units) Table 130. Europe Prescription Dermatological Medications Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Prescription Dermatological Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Prescription Dermatological Medications Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Prescription Dermatological Medications Market Share by Country (2021-2026) Table 134. Europe Prescription Dermatological Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Prescription Dermatological Medications Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Prescription Dermatological Medications Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Prescription Dermatological Medications Sales by Country (2021-2026) & (k units) Table 138. Asia-Pacific Prescription Dermatological Medications Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Prescription Dermatological Medications Sales Forecast by Country (2027-2032) & (k units) Table 140. Asia-Pacific Prescription Dermatological Medications Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Prescription Dermatological Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Prescription Dermatological Medications Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Prescription Dermatological Medications Market Share by Country (2021-2026) Table 144. Asia-Pacific Prescription Dermatological Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Prescription Dermatological Medications Market Share Forecast by Country (2027-2032) Table 146. Latin America Prescription Dermatological Medications Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Latin America Prescription Dermatological Medications Sales by Country (2021-2026) & (k units) Table 148. Latin America Prescription Dermatological Medications Sales Market Share by Country (2021-2026) Table 149. Latin America Prescription Dermatological Medications Sales Forecast by Country (2027-2032) & (k units) Table 150. Latin America Prescription Dermatological Medications Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Prescription Dermatological Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Prescription Dermatological Medications Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Prescription Dermatological Medications Market Share by Country (2021-2026) Table 154. Latin America Prescription Dermatological Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Prescription Dermatological Medications Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Prescription Dermatological Medications Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Prescription Dermatological Medications Sales by Country (2021-2026) & (k units) Table 158. Middle East and Africa Prescription Dermatological Medications Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Prescription Dermatological Medications Sales Forecast by Country (2027-2032) & (k units) Table 160. Middle East and Africa Prescription Dermatological Medications Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Prescription Dermatological Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Prescription Dermatological Medications Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Prescription Dermatological Medications Market Share by Country (2021-2026) Table 164. Middle East and Africa Prescription Dermatological Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Prescription Dermatological Medications Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Prescription Dermatological Medications Distributors List Table 169. Prescription Dermatological Medications Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Prescription Dermatological Medications Image Figure 2. Global Prescription Dermatological Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prescription Dermatological Medications Market Size (2021-2032) & (US$ Million) Figure 4. Global Prescription Dermatological Medications Sales (2021-2032) & (k units) Figure 5. Oral Image Figure 6. Global Oral Sales YoY Growth (2021-2032) & (k units) Figure 7. Topical Image Figure 8. Global Topical Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Prescription Dermatological Medications Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Prescription Dermatological Medications Market Share by Type 2025 VS 2032 Figure 11. North America Prescription Dermatological Medications Sales Market Share in Volume by Type in 2025 Figure 12. North America Prescription Dermatological Medications Sales Market Share in Value by Type in 2025 Figure 13. Europe Prescription Dermatological Medications Sales Market Share in Volume by Type in 2025 Figure 14. Europe Prescription Dermatological Medications Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Prescription Dermatological Medications Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Prescription Dermatological Medications Sales Market Share in Value by Type in 2025 Figure 17. Latin America Prescription Dermatological Medications Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Prescription Dermatological Medications Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Prescription Dermatological Medications Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Prescription Dermatological Medications Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Prescription Dermatological Medications Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Online Pharmacies Image Figure 24. Global Online Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 25. Hospital Pharmacies Image Figure 26. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 27. Retail Pharmacies Image Figure 28. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Prescription Dermatological Medications Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Prescription Dermatological Medications Market Share by Application 2025 VS 2032 Figure 31. North America Prescription Dermatological Medications Sales Market Share in Volume by Application in 2025 Figure 32. North America Prescription Dermatological Medications Sales Market Share in Value by Application in 2025 Figure 33. Europe Prescription Dermatological Medications Sales Market Share in Volume by Application in 2025 Figure 34. Europe Prescription Dermatological Medications Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Prescription Dermatological Medications Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Prescription Dermatological Medications Sales Market Share in Value by Application in 2025 Figure 37. Latin America Prescription Dermatological Medications Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Prescription Dermatological Medications Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Prescription Dermatological Medications Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Prescription Dermatological Medications Sales Market Share in Value by Application in 2025 Figure 41. North America Prescription Dermatological Medications Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Prescription Dermatological Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Prescription Dermatological Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Prescription Dermatological Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Prescription Dermatological Medications Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Prescription Dermatological Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Prescription Dermatological Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Prescription Dermatological Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Prescription Dermatological Medications Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Prescription Dermatological Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Prescription Dermatological Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Prescription Dermatological Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Prescription Dermatological Medications Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Prescription Dermatological Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Prescription Dermatological Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Prescription Dermatological Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Prescription Dermatological Medications Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Prescription Dermatological Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Prescription Dermatological Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Prescription Dermatological Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Prescription Dermatological Medications Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Prescription Dermatological Medications Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Topical
Applications
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
Companies covered
  • Novartis
  • Mylan Pharmaceuticals
  • Pfizer
  • Bristol-Myers Squibb
  • PharmaDerm
  • Galderma
  • Bausch Health
  • Barrier Therapeutics
  • Almirall

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Prescription Dermatological Medications Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Prescription Dermatological Medications Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Prescription Dermatological Medications Market by Type
  6. 1.3.1 Oral
  7. 1.3.2 Topical
  8. 1.4 Global Prescription Dermatological Medications Market Size by Type
  9. 1.4.1 Global Prescription Dermatological Medications Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Prescription Dermatological Medications Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Prescription Dermatological Medications Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Prescription Dermatological Medications Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Prescription Dermatological Medications Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Prescription Dermatological Medications Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Prescription Dermatological Medications Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Prescription Dermatological Medications Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Prescription Dermatological Medications Industry Trends
  2. 2.2 Prescription Dermatological Medications Industry Drivers
  3. 2.3 Prescription Dermatological Medications Industry Opportunities and Challenges
  4. 2.4 Prescription Dermatological Medications Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Prescription Dermatological Medications Revenue (2021-2026)
  2. 3.2 Global Top Players by Prescription Dermatological Medications Sales (2021-2026)
  3. 3.3 Global Top Players by Prescription Dermatological Medications Price (2021-2026)
  4. 3.4 Global Prescription Dermatological Medications Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prescription Dermatological Medications Major Company Production Sites & Headquarters
  6. 3.6 Global Prescription Dermatological Medications Company, Product Type & Application
  7. 3.7 Global Prescription Dermatological Medications Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prescription Dermatological Medications Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prescription Dermatological Medications Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prescription Dermatological Medications Tier 1, Tier 2, and Tier 3
4 Prescription Dermatological Medications Regional Status and Outlook
  1. 4.1 Global Prescription Dermatological Medications Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Prescription Dermatological Medications Historic Market Size by Region
  3. 4.2.1 Global Prescription Dermatological Medications Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Prescription Dermatological Medications Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Prescription Dermatological Medications Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Prescription Dermatological Medications Forecasted Market Size by Region
  7. 4.3.1 Global Prescription Dermatological Medications Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Prescription Dermatological Medications Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Prescription Dermatological Medications Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Prescription Dermatological Medications by Application
  1. 5.1 Prescription Dermatological Medications Market by Application
  2. 5.1.1 Online Pharmacies
  3. 5.1.2 Hospital Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Prescription Dermatological Medications Market Size by Application
  6. 5.2.1 Global Prescription Dermatological Medications Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Prescription Dermatological Medications Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Prescription Dermatological Medications Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Prescription Dermatological Medications Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Prescription Dermatological Medications Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Prescription Dermatological Medications Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Prescription Dermatological Medications Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Prescription Dermatological Medications Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Prescription Dermatological Medications Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Prescription Dermatological Medications Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Mylan Pharmaceuticals
  8. 6.2.1 Mylan Pharmaceuticals Company Information
  9. 6.2.2 Mylan Pharmaceuticals Business Overview
  10. 6.2.3 Mylan Pharmaceuticals Prescription Dermatological Medications Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mylan Pharmaceuticals Prescription Dermatological Medications Product Portfolio
  12. 6.2.5 Mylan Pharmaceuticals Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Prescription Dermatological Medications Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Prescription Dermatological Medications Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Bristol-Myers Squibb
  20. 6.4.1 Bristol-Myers Squibb Company Information
  21. 6.4.2 Bristol-Myers Squibb Business Overview
  22. 6.4.3 Bristol-Myers Squibb Prescription Dermatological Medications Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bristol-Myers Squibb Prescription Dermatological Medications Product Portfolio
  24. 6.4.5 Bristol-Myers Squibb Recent Developments
  25. 6.5 PharmaDerm
  26. 6.5.1 PharmaDerm Company Information
  27. 6.5.2 PharmaDerm Business Overview
  28. 6.5.3 PharmaDerm Prescription Dermatological Medications Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 PharmaDerm Prescription Dermatological Medications Product Portfolio
  30. 6.5.5 PharmaDerm Recent Developments
  31. 6.6 Galderma
  32. 6.6.1 Galderma Company Information
  33. 6.6.2 Galderma Business Overview
  34. 6.6.3 Galderma Prescription Dermatological Medications Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Galderma Prescription Dermatological Medications Product Portfolio
  36. 6.6.5 Galderma Recent Developments
  37. 6.7 Bausch Health
  38. 6.7.1 Bausch Health Company Information
  39. 6.7.2 Bausch Health Business Overview
  40. 6.7.3 Bausch Health Prescription Dermatological Medications Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bausch Health Prescription Dermatological Medications Product Portfolio
  42. 6.7.5 Bausch Health Recent Developments
  43. 6.8 Barrier Therapeutics
  44. 6.8.1 Barrier Therapeutics Company Information
  45. 6.8.2 Barrier Therapeutics Business Overview
  46. 6.8.3 Barrier Therapeutics Prescription Dermatological Medications Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Barrier Therapeutics Prescription Dermatological Medications Product Portfolio
  48. 6.8.5 Barrier Therapeutics Recent Developments
  49. 6.9 Almirall
  50. 6.9.1 Almirall Company Information
  51. 6.9.2 Almirall Business Overview
  52. 6.9.3 Almirall Prescription Dermatological Medications Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Almirall Prescription Dermatological Medications Product Portfolio
  54. 6.9.5 Almirall Recent Developments
7 North America by Country
  1. 7.1 North America Prescription Dermatological Medications Sales by Country
  2. 7.1.1 North America Prescription Dermatological Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Prescription Dermatological Medications Sales by Country (2021-2026)
  4. 7.1.3 North America Prescription Dermatological Medications Sales Forecast by Country (2027-2032)
  5. 7.2 North America Prescription Dermatological Medications Market Size by Country
  6. 7.2.1 North America Prescription Dermatological Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Prescription Dermatological Medications Market Size by Country (2021-2026)
  8. 7.2.3 North America Prescription Dermatological Medications Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Prescription Dermatological Medications Sales by Country
  2. 8.1.1 Europe Prescription Dermatological Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Prescription Dermatological Medications Sales by Country (2021-2026)
  4. 8.1.3 Europe Prescription Dermatological Medications Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Prescription Dermatological Medications Market Size by Country
  6. 8.2.1 Europe Prescription Dermatological Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Prescription Dermatological Medications Market Size by Country (2021-2026)
  8. 8.2.3 Europe Prescription Dermatological Medications Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Prescription Dermatological Medications Sales by Country
  2. 9.1.1 Asia-Pacific Prescription Dermatological Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Prescription Dermatological Medications Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Prescription Dermatological Medications Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Prescription Dermatological Medications Market Size by Country
  6. 9.2.1 Asia-Pacific Prescription Dermatological Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Prescription Dermatological Medications Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Prescription Dermatological Medications Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Prescription Dermatological Medications Sales by Country
  2. 10.1.1 South America Prescription Dermatological Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Prescription Dermatological Medications Sales by Country (2021-2026)
  4. 10.1.3 South America Prescription Dermatological Medications Sales Forecast by Country (2027-2032)
  5. 10.2 South America Prescription Dermatological Medications Market Size by Country
  6. 10.2.1 South America Prescription Dermatological Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Prescription Dermatological Medications Market Size by Country (2021-2026)
  8. 10.2.3 South America Prescription Dermatological Medications Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Prescription Dermatological Medications Sales by Country
  2. 11.1.1 Middle East and Africa Prescription Dermatological Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Prescription Dermatological Medications Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Prescription Dermatological Medications Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Prescription Dermatological Medications Market Size by Country
  6. 11.2.1 Middle East and Africa Prescription Dermatological Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Prescription Dermatological Medications Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Prescription Dermatological Medications Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Prescription Dermatological Medications Value Chain Analysis
  2. 12.1.1 Prescription Dermatological Medications Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Prescription Dermatological Medications Production Mode & Process
  7. 12.2 Prescription Dermatological Medications Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Prescription Dermatological Medications Distributors
  10. 12.2.3 Prescription Dermatological Medications Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst